459 related articles for article (PubMed ID: 30306544)
1. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Hwang EC; Gandhi S; Jung JH; Imamura M; Kim MH; Pang R; Dahm P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007360. PubMed ID: 30306544
[TBL] [Abstract][Full Text] [Related]
2. Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; Kim J; MacDonald R; Reddy B; Kim MH; Dahm P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012615. PubMed ID: 29161773
[TBL] [Abstract][Full Text] [Related]
3. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Garimella PS; Fink HA; Macdonald R; Wilt TJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007360. PubMed ID: 19821408
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
Pang R; Zhou XY; Wang X; Wang B; Yin XL; Bo H; Jung JH
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012336. PubMed ID: 33567116
[TBL] [Abstract][Full Text] [Related]
5. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
[TBL] [Abstract][Full Text] [Related]
6. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010060. PubMed ID: 30480763
[TBL] [Abstract][Full Text] [Related]
8. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
9. Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia.
Kang TW; Jung JH; Hwang EC; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013251. PubMed ID: 32212174
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
11. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
[TBL] [Abstract][Full Text] [Related]
12. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
[TBL] [Abstract][Full Text] [Related]
13. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement.
Franco JV; Trivisonno L; Sgarbossa NJ; Alvez GA; Fieiras C; Escobar Liquitay CM; Jung JH
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001423. PubMed ID: 37345871
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
BJU Int; 2019 Jul; 124(1):27-34. PubMed ID: 30681264
[TBL] [Abstract][Full Text] [Related]
15. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.
Alexander CE; Scullion MM; Omar MI; Yuan Y; Mamoulakis C; N'Dow JM; Chen C; Lam TB
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD009629. PubMed ID: 31792928
[TBL] [Abstract][Full Text] [Related]
16. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction.
Silva V; Grande AJ; Peccin MS
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012044. PubMed ID: 30953341
[TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement in men with sexual dysfunction.
Lee H; Hwang EC; Oh CK; Lee S; Yu HS; Lim JS; Kim HW; Walsh T; Kim MH; Jung JH; Dahm P
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013071. PubMed ID: 38224135
[TBL] [Abstract][Full Text] [Related]
18. Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized multicenter study.
Shirakawa T; Haraguchi T; Shigemura K; Morishita S; Minayoshi K; Miyazaki J; Yamada Y; Miyake H; Tanaka K; Fujisawa M
Int J Urol; 2013 Sep; 20(9):903-10. PubMed ID: 23252453
[TBL] [Abstract][Full Text] [Related]
19. New alpha blockers to treat male lower urinary tract symptoms.
Hwang EC; Gandhi S; Jung JH
Curr Opin Urol; 2018 May; 28(3):273-276. PubMed ID: 29613909
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis.
Chai Y; Zhou Z; Cui Y; Che X; Zhang Y
Andrologia; 2021 Oct; 53(9):e14166. PubMed ID: 34189764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
